John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 17,418 shares at $8.35 ($146K) on 2022-07-05, disclosed to the SEC on 2022-07-07.
Open-market sale of $146k EWTX by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.35 | 8,186 | $68K | 46.9% |
| 2 | $8.35 | 8,186 | $68K | 46.9% |
| 3 | $8.54 | 1,046 | $9K | 6.1% |
| Total | $8.36 avg | 17,418 | $146K | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |